BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ning J, Rietjens IMCM, Strikwold M. Integrating physiologically based kinetic (PBK) and Monte Carlo modelling to predict inter-individual and inter-ethnic variation in bioactivation and liver toxicity of lasiocarpine. Arch Toxicol 2019;93:2943-60. [PMID: 31511935 DOI: 10.1007/s00204-019-02563-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 de Bruijn VMP, Rietjens IMCM, Bouwmeester H. Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasis. Arch Toxicol. [DOI: 10.1007/s00204-022-03345-8] [Reference Citation Analysis]
2 Shi M, Dong Y, Bouwmeester H, Rietjens IMCM, Strikwold M. In vitro-in silico-based prediction of inter-individual and inter-ethnic variations in the dose-dependent cardiotoxicity of R- and S-methadone in humans. Arch Toxicol 2022. [PMID: 35604418 DOI: 10.1007/s00204-022-03309-y] [Reference Citation Analysis]
3 Widjaja F, Alhejji Y, Rietjens IMCM. The Role of Kinetics as Key Determinant in Toxicity of Pyrrolizidine Alkaloids and Their N-Oxides. Planta Med 2021. [PMID: 34741297 DOI: 10.1055/a-1582-9794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gibson CR, Wang YH, Varkhede N, Ma B. Variability in Human In Vitro Enzyme Kinetics. Methods Mol Biol 2021;2342:443-79. [PMID: 34272704 DOI: 10.1007/978-1-0716-1554-6_16] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 He Y, Zhu L, Ma J, Lin G. Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids. Arch Toxicol 2021;95:1917-42. [PMID: 34003343 DOI: 10.1007/s00204-021-03060-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
6 Matossian MD, Giardina AA, Wright MK, Elliott S, Loch MM, Nguyen K, Zea AH, Lau FH, Moroz K, Riker AI, Jones SD, Martin EC, Bunnell BA, Miele L, Collins-Burow BM, Burow ME. Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer. Womens Health Rep (New Rochelle) 2020;1:383-92. [PMID: 33786503 DOI: 10.1089/whr.2020.0037] [Reference Citation Analysis]
7 Gilbert-Sandoval I, Wesseling S, Rietjens IMCM. Predicting the Acute Liver Toxicity of Aflatoxin B1 in Rats and Humans by an In Vitro-In Silico Testing Strategy. Mol Nutr Food Res 2020;64:e2000063. [PMID: 32421213 DOI: 10.1002/mnfr.202000063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]